Because I’m a Brit, in terms of DCVAX-L, I know that our NHS is currently very overburden, and in the middle of a funding crisis. Which means that every expenditure is being looked at, in an attempt to slash costs.
As such, the NICE have, out of statutory fiscal necessity, become tighter than a ducks arsehole, in terms of the cost vs benefit metric.
In 2024, there simply isn’t the available budget set aside, to take a statistical chance on.
So where is the future market to satiate & underpin 1 billion shares ?
Market Data 
Markets 
AI
